Previously, it has been reported that plasma PAI-1 levels have been shown to predict the risk of arterial hypertension [38, 39], to increase in normotensive subjects by activation of RAAS by either dietary sodium restriction or diuretic use, and decrease by interruption of RAAS with an angiotensin-converting enzyme inhibitor [40]. The gene discussed is ACE; the disease is Hypertension.